HMS (NASDAQ:HMSY) had its price objective lifted by investment analysts at Cantor Fitzgerald to $31.00 in a report issued on Monday, The Fly reports. The firm presently has a “neutral” rating on the business services provider’s stock. Cantor Fitzgerald’s price objective would indicate a potential downside of 13.19% from the company’s current price.
Other research analysts have also issued reports about the company. Credit Suisse Group upped their price objective on HMS from $27.00 to $33.00 and gave the company an “outperform” rating in a report on Wednesday, August 22nd. Citigroup raised HMS from a “neutral” rating to a “buy” rating and upped their price objective for the company from $25.00 to $35.00 in a report on Monday, August 6th. Zacks Investment Research raised HMS from a “hold” rating to a “buy” rating and set a $26.00 price objective on the stock in a report on Tuesday, July 10th. Leerink Swann upped their price objective on HMS from $25.00 to $35.00 and gave the company an “outperform” rating in a report on Monday, August 6th. Finally, BidaskClub lowered HMS from a “strong-buy” rating to a “buy” rating in a report on Thursday, September 20th. Four investment analysts have rated the stock with a hold rating, seven have assigned a buy rating and two have issued a strong buy rating to the company. HMS has a consensus rating of “Buy” and an average price target of $32.00.
Shares of NASDAQ HMSY opened at $35.71 on Monday. The company has a current ratio of 4.04, a quick ratio of 3.87 and a debt-to-equity ratio of 0.37. HMS has a one year low of $14.88 and a one year high of $36.25. The firm has a market capitalization of $2.85 billion, a price-to-earnings ratio of 83.05, a PEG ratio of 4.08 and a beta of 1.32.
HMS (NASDAQ:HMSY) last issued its quarterly earnings data on Friday, November 2nd. The business services provider reported $0.31 EPS for the quarter, beating analysts’ consensus estimates of $0.21 by $0.10. HMS had a return on equity of 10.63% and a net margin of 8.01%. The firm had revenue of $154.20 million for the quarter, compared to analyst estimates of $140.93 million. During the same period in the prior year, the firm posted $0.19 EPS. The company’s revenue for the quarter was up 22.7% on a year-over-year basis. Equities analysts forecast that HMS will post 0.76 earnings per share for the current fiscal year.
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. First Quadrant L P CA acquired a new stake in shares of HMS during the 3rd quarter worth $107,000. Macquarie Group Ltd. grew its holdings in shares of HMS by 344.4% during the 2nd quarter. Macquarie Group Ltd. now owns 8,000 shares of the business services provider’s stock worth $173,000 after purchasing an additional 6,200 shares in the last quarter. NumerixS Investment Technologies Inc acquired a new stake in shares of HMS during the 2nd quarter worth $176,000. Sandy Spring Bank acquired a new stake in shares of HMS during the 2nd quarter worth $188,000. Finally, Stifel Financial Corp acquired a new stake in shares of HMS during the 1st quarter worth $210,000. 95.24% of the stock is currently owned by institutional investors.
HMS Holdings Corp., through its subsidiaries, provides cost containment solutions in the United States healthcare marketplace. It provides coordination of benefits services to government and commercial healthcare payers and sponsors to coordinate benefits for claims; and payment integrity services that ensure healthcare claims billed are accurate and appropriate, as well as offers care management and consumer engagement solutions.
Further Reading: How can investors find ex-dividend dates?
Receive News & Ratings for HMS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HMS and related companies with MarketBeat.com's FREE daily email newsletter.